none 10.31254/phyto.2025.14108 BioMed Research Publishers BioMed Research Publishers 16195 174147564 316921 20250327162658435 10.31254 2025-03-27T16:27:23Z 2025-03-27T16:27:19Z 0 The Journal of Phytopharmacology J Phytopharmacol 2320480X 10.31254/phyto https://phytopharmajournal.com/ 3 23 2025 14 1 Dennis Jack Opwoko https://orcid.org/0000-0002-6282-3622 Joseph Mwanzia Nguta http://orcid.org/0000-0002-4591-9999 Isaac Ole Mapenay https://orcid.org/0000-0002-1646-0525 Plants have served as a rich source of bioactive compounds leading to their utilization in folk medicine for a variety of diseases. Plants have also been explored in development of synthetic drugs. In contrast to plants benefit in management of various conditions, they have toxic compounds and the safety of these plants is not extensively analysed for toxicity profile. In addition, the mechanism of action, pharmacokinetics, bioavailability, synergistic effects and clinical validation data on plants are still under-researched. This review article explores the pharmacology, toxicology and phytochemical composition of Cassipourea malosana (Rhizophoraceae) documented in manifold journals and articles. This review article has been created with the assistance of articles, books, peer reviewed articles, validated internet sources, theses, Science Direct and Google Scholar. Cassipourea malosana (Rhizophoraceae) has been employed in treatment of various disease like: stomach ailments, wound healing, treatment of fever and relieve of headache. Hence, these uses can be attributed to diversity of phytochemical constituents including but not limited to tannins, alkaloids, flavonoids and saponins. Cassipourea malosana (Rhizophoraceae) pharmacology and toxicology have not been extensively studied. Further studies are needed to demonstrate additional phytochemical constituents, pharmacological activities and toxicity profiles. Cassipourea malosana (Rhizophoraceae) will provide new medication in the management of diseases to supplement conventional drugs which have been linked to various adverse effects during their use. 3 23 2025 55 61 1 10.31254/biomed-crossmark-policy www.biomedresearch.org false 10.31254/phyto.2025.14108 https://phytopharmajournal.com/articles/abstracts/804/year=2025&vol=14&issue=1